Kamil Lisek
Trieste, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Targeting SHP2 phosphatase in breast cancer overcomes RTK-mediated resistance to PI3K inhibitors.
Journal: Breast cancer research : BCR
Published: February 22, 2021
YAP and β-Catenin Cooperate to Drive Oncogenesis in Basal Breast Cancer.
Journal: Cancer research
Published: August 17, 2020
Mutant p53 tunes the NRF2-dependent antioxidant response to support survival of cancer cells.
Journal: Oncotarget
Published: August 20, 2017
Mechanical cues control mutant p53 stability through a mevalonate-RhoA axis.
Journal: Nature cell biology
Published: December 22, 2016
Multi-omics reveals global effects of mutant p53 gain-of-function.
Journal: Cell cycle (Georgetown, Tex.)
Published: July 27, 2016
Mutant p53-Nrf2 axis regulates the proteasome machinery in cancer.
Journal: Molecular & cellular oncology
Published: July 23, 2016
Mutant p53: One, No One, and One Hundred Thousand.
Journal: Frontiers in oncology
Published: October 19, 2015
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer.
Journal: Nature cell biology
Published: September 30, 2015
Mutant p53 inhibits miRNA biogenesis by interfering with the microprocessor complex.
Journal: Oncogene
Published: May 13, 2015
Nuclear architecture dictates HIV-1 integration site selection.
Journal: Nature
Published: December 05, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026